+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Short Bowel Syndrome Market Intelligence Report - Global Forecast to 2027

  • PDF Icon

    Report

  • 120 Pages
  • July 2022
  • Region: Global
  • Think Market Intelligence
  • ID: 5624302
UP TO OFF until Dec 31st 2022
The Global Short Bowel Syndrome Market is projected to reach USD 1,625.11 million by 2027 from USD 594.91 million in 2021, at a CAGR 18.23% during the forecast period.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available.

In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

  • The Americas Short Bowel Syndrome Market size was estimated at USD 203.22 million in 2021, is expected to reach USD 237.78 million in 2022, and is projected to grow at a CAGR of 18.26% to reach USD 555.95 million by 2027.
  • The Asia-Pacific Short Bowel Syndrome Market size was estimated at USD 179.53 million in 2021, is expected to reach USD 211.65 million in 2022, and is projected to grow at a CAGR of 18.55% to reach USD 498.44 million by 2027.
  • The Europe, Middle East & Africa Short Bowel Syndrome Market size was estimated at USD 212.15 million in 2021, is expected to reach USD 246.13 million in 2022, and is projected to grow at a CAGR of 17.93% to reach USD 570.71 million by 2027.

Market Segmentation & Coverage:


The report on short bowel syndrome identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. This market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the short bowel syndrome to forecast the revenues and analyze the trends in each of the following sub-markets:

Drug Class:

  • GLP-2
  • Glutamine
  • Growth Hormone

Distribution Channel:

  • Hospital Pharmacies
  • Online Sales
  • Retail Pharmacies

Region:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
  • Europe, Middle East & Africa
    • France
    • Germany
    • Italy
    • Netherlands
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • United Arab Emirates
    • United Kingdom

Company Usability Profiles:

  • 9 Meters Biopharma, Inc.
  • Adocia SAS
  • Ardelyx Inc.
  • AstraZeneca PLC
  • Emmaus Life Sciences, Inc.
  • Merck KGaA
  • Nestlé S.A.
  • Novartis International AG
  • OPKO Health, Inc.
  • Oxthera AB
  • Pfizer Inc.
  • PhaseBio Pharmaceuticals Inc.
  • Sancilio and Company, Inc.
  • Swedish Orphan Biovitrum AB
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • VectivBio AG
  • Viatris Inc.
  • Zealand Pharma A/S
Frequently Asked Questions about the Short Bowel Syndrome Market

What is the estimated value of the Short Bowel Syndrome Market?

The Short Bowel Syndrome Market was estimated to be valued at $594.91 Million in 2021.

What is the growth rate of the Short Bowel Syndrome Market?

The growth rate of the Short Bowel Syndrome Market is 18.2%, with an estimated value of $1625.11 Million by 2027.

What is the forecasted size of the Short Bowel Syndrome Market?

The Short Bowel Syndrome Market is estimated to be worth $1625.11 Million by 2027.

Who are the key companies in the Short Bowel Syndrome Market?

Key companies in the Short Bowel Syndrome Market include 9 Meters Biopharma, Inc., Adocia SAS, Ardelyx Inc., AstraZeneca PLC, Emmaus Life Sciences, Inc., Merck KGaA, Nestlé S.A., Novartis International AG and Oxthera AB.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Market Overview
4. Americas Short Bowel Syndrome Market
4.1. Introduction
4.2. Argentina
4.3. Brazil
4.4. Canada
4.5. Mexico
4.6. United States
5. Asia-Pacific Short Bowel Syndrome Market
5.1. Introduction
5.2. Australia
5.3. China
5.4. India
5.5. Indonesia
5.6. Japan
5.7. Malaysia
5.8. Philippines
5.9. Singapore
5.10. South Korea
5.11. Taiwan
5.12. Thailand
6. Europe, Middle East & Africa Short Bowel Syndrome Market
6.1. Introduction
6.2. France
6.3. Germany
6.4. Italy
6.5. Netherlands
6.6. Qatar
6.7. Russia
6.8. Saudi Arabia
6.9. South Africa
6.10. Spain
6.11. United Arab Emirates
6.12. United Kingdom
7. Company Usability Profiles
7.1. 9 Meters Biopharma, Inc.
7.2. Adocia SAS
7.3. Ardelyx Inc.
7.4. AstraZeneca PLC
7.5. Emmaus Life Sciences, Inc.
7.6. Merck KGaA
7.7. Nestlé S.A.
7.8. Novartis International AG
7.9. OPKO Health, Inc.
7.10. Oxthera AB
7.11. Pfizer Inc.
7.12. PhaseBio Pharmaceuticals Inc.
7.13. Sancilio and Company, Inc.
7.14. Swedish Orphan Biovitrum AB
7.15. Takeda Pharmaceutical Company Limited
7.16. Teva Pharmaceutical Industries Ltd.
7.17. VectivBio AG
7.18. Viatris Inc.
7.19. Zealand Pharma A/S
List of Figures
Figure 1. Global Short Bowel Syndrome Market: Research Process
Figure 2. Global Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 3. Global Short Bowel Syndrome Market Size, by Region, 2021 Vs 2027 (%)
Figure 4. Global Short Bowel Syndrome Market Size, by Region, 2021 Vs 2027 (USD Million)
Figure 5. Competitive Strategic Window For Global Short Bowel Syndrome Market Size, by Region, 2027
Figure 6. Americas Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 7. Americas Short Bowel Syndrome Market Size, by Country, 2021 Vs 2027 (%)
Figure 8. Americas Short Bowel Syndrome Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 9. Competitive Strategic Window For Americas Short Bowel Syndrome Market Size, by Country, 2027
Figure 10. Argentina Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 11. Brazil Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 12. Canada Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 13. Mexico Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 14. United States Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 15. United States Short Bowel Syndrome Market Size, by State, 2021 Vs 2027 (%)
Figure 16. United States Short Bowel Syndrome Market Size, by State, 2021 Vs 2027 (USD Million)
Figure 17. Competitive Strategic Window For United States Short Bowel Syndrome Market Size, by State, 2027
Figure 18. Asia-Pacific Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 19. Asia-Pacific Short Bowel Syndrome Market Size, by Country, 2021 Vs 2027 (%)
Figure 20. Asia-Pacific Short Bowel Syndrome Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 21. Competitive Strategic Window For Asia-Pacific Short Bowel Syndrome Market Size, by Country, 2027
Figure 22. Australia Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 23. China Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 24. India Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 25. Indonesia Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 26. Japan Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 27. Malaysia Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 28. Philippines Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 29. Singapore Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 30. South Korea Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 31. Taiwan Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 32. Thailand Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 33. Europe, Middle East & Africa Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 34. Europe, Middle East & Africa Short Bowel Syndrome Market Size, by Country, 2021 Vs 2027 (%)
Figure 35. Europe, Middle East & Africa Short Bowel Syndrome Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 36. Competitive Strategic Window For Europe, Middle East & Africa Short Bowel Syndrome Market Size, by Country, 2027
Figure 37. France Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 38. Germany Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 39. Italy Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 40. Netherlands Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 41. Qatar Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 42. Russia Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 43. Saudi Arabia Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 44. South Africa Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 45. Spain Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 46. United Arab Emirates Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Figure 47. United Kingdom Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
List of Tables
Table 1. Global Short Bowel Syndrome Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016-2020
Table 3. Global Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 4. Global Short Bowel Syndrome Market Size, by Region, 2019-2027 (USD Million)
Table 5. Global Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 6. Global Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 7. Americas Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 8. Americas Short Bowel Syndrome Market Size, by Country, 2019-2027 (USD Million)
Table 9. Americas Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 10. Americas Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 11. Argentina Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 12. Argentina Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 13. Argentina Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 14. Brazil Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 15. Brazil Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 16. Brazil Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 17. Canada Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 18. Canada Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 19. Canada Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 20. Mexico Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 21. Mexico Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 22. Mexico Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 23. United States Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 24. United States Short Bowel Syndrome Market Size, by State, 2019-2027 (USD Million)
Table 25. United States Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 26. United States Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 27. Asia-Pacific Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 28. Asia-Pacific Short Bowel Syndrome Market Size, by Country, 2019-2027 (USD Million)
Table 29. Asia-Pacific Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 30. Asia-Pacific Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 31. Australia Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 32. Australia Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 33. Australia Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 34. China Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 35. China Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 36. China Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 37. India Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 38. India Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 39. India Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 40. Indonesia Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 41. Indonesia Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 42. Indonesia Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 43. Japan Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 44. Japan Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 45. Japan Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 46. Malaysia Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 47. Malaysia Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 48. Malaysia Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 49. Philippines Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 50. Philippines Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 51. Philippines Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 52. Singapore Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 53. Singapore Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 54. Singapore Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 55. South Korea Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 56. South Korea Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 57. South Korea Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 58. Taiwan Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 59. Taiwan Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 60. Taiwan Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 61. Thailand Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 62. Thailand Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 63. Thailand Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 64. Europe, Middle East & Africa Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 65. Europe, Middle East & Africa Short Bowel Syndrome Market Size, by Country, 2019-2027 (USD Million)
Table 66. Europe, Middle East & Africa Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 67. Europe, Middle East & Africa Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 68. France Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 69. France Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 70. France Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 71. Germany Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 72. Germany Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 73. Germany Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 74. Italy Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 75. Italy Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 76. Italy Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 77. Netherlands Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 78. Netherlands Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 79. Netherlands Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 80. Qatar Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 81. Qatar Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 82. Qatar Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 83. Russia Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 84. Russia Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 85. Russia Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 86. Saudi Arabia Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 87. Saudi Arabia Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 88. Saudi Arabia Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 89. South Africa Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 90. South Africa Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 91. South Africa Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 92. Spain Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 93. Spain Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 94. Spain Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 95. United Arab Emirates Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 96. United Arab Emirates Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 97. United Arab Emirates Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 98. United Kingdom Short Bowel Syndrome Market Size, 2019-2027 (USD Million)
Table 99. United Kingdom Short Bowel Syndrome Market Size, by Drug Class, 2019-2027 (USD Million)
Table 100. United Kingdom Short Bowel Syndrome Market Size, by Distribution Channel, 2019-2027 (USD Million)

Companies Mentioned

  • 9 Meters Biopharma, Inc.
  • Adocia SAS
  • Ardelyx Inc.
  • AstraZeneca PLC
  • Emmaus Life Sciences, Inc.
  • Merck KGaA
  • Nestlé S.A.
  • Novartis International AG
  • OPKO Health, Inc.
  • Oxthera AB
  • Pfizer Inc.
  • PhaseBio Pharmaceuticals Inc.
  • Sancilio and Company, Inc.
  • Swedish Orphan Biovitrum AB
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • VectivBio AG
  • Viatris Inc.
  • Zealand Pharma A/S

Methodology

Loading
LOADING...